Search

Your search keyword '"Chang, Yo-Chen"' showing total 207 results
Start Over Author "Chang, Yo-Chen" Publication Year Range Last 50 years
207 results on '"Chang, Yo-Chen"'

4. Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis

Author

Chen, Wei-Dar, primary, Wu, Cheng-Hsiu, additional, Wu, Po-Yi, additional, Lin, Chang-Ping, additional, Ou, Liang-Shiou, additional, Hwang, De-Kuang, additional, Sheu, Shwu-Jiuan, additional, Chiang, Wei-Yu, additional, Chang, Yo-Chen, additional, Lin, Chun-Ju, additional, Chan, Wei-Chun, additional, Fang, Yueh-Fu, additional, Chien-Chieh Huang, Jerry, additional, Kao, Tzu-En, additional, Chiu, Fang-Yi, additional, Hsia, Ning-Yi, additional, and Hwang, Yih-Shiou, additional

Published
2024
Full Text
View/download PDF

10. Nordalbergin Exerts Anti-Neuroinflammatory Effects by Attenuating MAPK Signaling Pathway, NLRP3 Inflammasome Activation and ROS Production in LPS-Stimulated BV2 Microglia

Author

Lo, Jung, primary, Wu, Hsin-En, additional, Liu, Ching-Chih, additional, Chang, Kun-Che, additional, Lee, Po-Yen, additional, Liu, Po-Len, additional, Huang, Shu-Pin, additional, Wu, Pei-Chang, additional, Lin, Tzu-Chieh, additional, Lai, Yu-Hung, additional, Chang, Yo-Chen, additional, Chen, Yuan-Ru, additional, Lee, Sheng-I, additional, Huang, Yu-Kai, additional, Wang, Shu-Chi, additional, and Li, Chia-Yang, additional

Published
2023
Full Text
View/download PDF

14. Magnolol regulates miR-200c-3p to inhibit epithelial–mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo

Author

Lai, Yu-Hung, primary, Liu, Wei-Lun, additional, Lee, Tsung-Ying, additional, Kuo, Chung-Wen, additional, Liu, Yu-Ru, additional, Huang, Chi-Yuan, additional, Chen, Yung-Hsiang, additional, Chen, I-Ling, additional, Wu, Szu-Hui, additional, Wang, Shu-Chi, additional, Lee, Po-Yen, additional, Liu, Ching-Chih, additional, Lo, Jung, additional, Chang, Yo-Chen, additional, Kuo, Hsuan-Fu, additional, Hsieh, Chong-Chao, additional, Li, Chia-Yang, additional, and Liu, Po-Len, additional

Published
2023
Full Text
View/download PDF

16. Intravitreal Aflibercept for Patients with Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Retrospective Trial.

Author

Cheng, Kai-Chun, Chiu, Chien-Chih, Chen, Kuo-Jen, and Chang, Yo-Chen

Subjects
VISUAL acuity, OPTICAL coherence tomography, VISUAL fields, AFLIBERCEPT, INTRAVITREAL injections
Abstract

Purpose: This study aimed to investigate whether intravitreal aflibercept was safe and effective in patients with acute nonarteritic anterior ischemic optic neuropathy (NAION). Methods: This was a chart study of 25 individuals with acute NAION (25 eyes). An intravitreal injection of 2 mg/0.05 mL of aflibercept was administered to fifteen participants. The remaining ten patients in the control group were given standard care. The researchers measured the initial visual acuity, retinal nerve fiber layer thickness (RNFLT), and automated perimetry. During the follow-up period, the researchers measured the final visual acuity, RNFLT, automated perimetry, and side effects. Results: Visual acuity and visual field assessment were significantly improved in the study group, and optical coherence tomography testing demonstrated significant disc edema resolution. The therapy results differed significantly between the two groups regarding visual outcomes (F = 0.027, p = 0.039) and RNFLT decrease (F = 5.507, p = 0.003). However, the difference in visual field alterations was not significant (F = 0.724, p = 0.387). Conclusions: Intravitreal injection of aflibercept can significantly improve visual acuity and resolve disc edema in patients with acute NAION. Intravitreal aflibercept may be an alternative treatment for acute NAION. However, a large series investigation is needed to assess the long-term therapeutic benefit and safety of intravitreal aflibercept in patients with acute NAION. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

17. Optical Coherence Tomography Assessment of Macular Thickness in Alzheimer's Dementia with Different Neuropsychological Severities.

Author

Kao, Chia-Chen, Hsieh, Hui-Min, Chang, Yo-Chen, Chu, Hui-Chen, Yang, Yuan-Han, and Sheu, Shwu-Jiuan

Subjects
ALZHEIMER'S disease, OPTICAL coherence tomography, MINI-Mental State Examination, RETINAL imaging, GRIDS (Cartography)
Abstract

This retrospective case-control study aimed to investigate associations between disease severity of Alzheimer's dementia (AD) and macular thickness. Data of patients with AD who were under medication (n = 192) between 2013 and 2020, as well as an age- and sex-matched control group (n = 200) with normal cognitive function, were included. AD patients were divided into subgroups according to scores of the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR). Macular thickness was analyzed via the Early Treatment Diabetic Retinopathy Study (ETDRS) grid map. AD patients had significant reductions in full macula layers, including inner circle, outer inferior area, and outer nasal area of the macula. Similar retinal thinning was noted in ganglion cells and inner plexiform layers. Advanced AD patients (MMSE score < 18 or CDR ≥ 1) showed more advanced reduction of macular thickness than the AD group (CDR = 0.5 or MMSE ≥ 18), indicating that severe cognitive impairment was associated with thinner macular thickness. Advanced AD is associated with significant macula thinning in full retina and inner plexiform layers, especially at the inner circle of the macula. Macular thickness may be a useful biomarker of AD disease severity. Retinal imaging may be a non-invasive, low-cost surrogate for AD. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

22. Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation

Author

Lo, Jung, primary, Liu, Ching-Chih, additional, Li, Yueh-Shan, additional, Lee, Po-Yen, additional, Liu, Po-Len, additional, Wu, Pei-Chang, additional, Lin, Tzu-Chieh, additional, Chen, Chi-Shuo, additional, Chiu, Chien-Chih, additional, Lai, Yu-Hung, additional, Chang, Yo-Chen, additional, Wu, Hsin-En, additional, Chen, Yuan-Ru, additional, Huang, Yu-Kai, additional, Huang, Shu-Pin, additional, Wang, Shu-Chi, additional, and Li, Chia-Yang, additional

Published
2022
Full Text
View/download PDF

25. Clinical Manifestations and Outcomes of Tubercular Uveitis in Taiwan—A Ten-Year Multicenter Retrospective Study

Author

Lin, Chun-Ju, primary, Hsia, Ning-Yi, additional, Hwang, De-Kuang, additional, Hwang, Yih-Shiou, additional, Chang, Yo-Chen, additional, Lee, Yueh-Chang, additional, Hsu, Yung-Ray, additional, Yeh, Po-Ting, additional, Lin, Chang-Ping, additional, Chen, Hsi-Fu, additional, Jan, Wei-Chun, additional, Chiang, Wei-Yu, additional, and Tsai, Ming-Ling, additional

Published
2022
Full Text
View/download PDF

29. Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells

Author

Lee, Po-Yen, primary, Lai, Yu-Hung, additional, Liu, Po-Len, additional, Liu, Ching-Chih, additional, Su, Chia-Cheng, additional, Chiu, Fang-Yen, additional, Cheng, Wei-Chung, additional, Hsu, Shiuh-Liang, additional, Cheng, Kai-Chun, additional, Chiu, Li-Yi, additional, Kao, Tzu-En, additional, Lin, Chia-Ching, additional, Chang, Yo-Chen, additional, Wang, Shu-Chi, additional, and Li, Chia-Yang, additional

Published
2021
Full Text
View/download PDF

31. Reply

Author

Liu, Pei-Kang, primary, Chang, Yo-Chen, additional, Chuang, Cheng-Hao, additional, and Tsai, Ming-Ju, additional

Published
2021
Full Text
View/download PDF

40. Thrombospondin 1‐induced exosomal proteins attenuate hypoxia‐induced paraptosis in corneal epithelial cells and promote wound healing

Author

Lai, Yu‐Hung, primary, Lee, Po‐Yen, additional, Lu, Chi‐Yu, additional, Liu, Yu‐Ru, additional, Wang, Shu‐Chi, additional, Liu, Ching‐Chih, additional, Chang, Yo‐Chen, additional, Chen, Yung‐Hsiang, additional, Su, Chia‐Cheng, additional, Li, Chia‐Yang, additional, and Liu, Po‐Len, additional

Published
2020
Full Text
View/download PDF

49. Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID‐19 vaccination.

Author

Lee, Daniel Yu, Wu, Horng‐Jiun, Cheng, Kai‐Chun, and Chang, Yo‐Chen

Subjects
COVID-19 vaccines, EDEMA, HEPATITIS B vaccines, OPTIC neuritis, OPTIC disc edema, DIABETIC retinopathy, IRIDOCYCLITIS
Abstract

Fluorescein angiography showed disc edema with dye leakage (OD; Figure 1C) and a single point of hyperfluorescence with focal area of retinal pigment epithelium (RPE) decompensation over the temporal superior vessel arcade (OS; Figure 1D). At the visit of six-week follow-up, the disc edema (OD) and the serous detachment (OS) were both reduced (Figure 1E,F) with best corrected visual acuity (BCVA) restored to 20/20 (OD) and 20/25 (OS). (A) Initial fundus photography of the right eye shows optic disc edema. [Extracted from the article]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results